DYSF p.Ser1726Pro
c.5176T>C · rs1573060017 · VCV665724
ClinGen expert panel — Limb Girdle Muscular Dystrophy VCEP
Likely Pathogenic for autosomal recessive limb-girdle muscular dystrophy. Applied ACMG criteria (verbatim):
PM2_Supporting PP4_Strong PP3 PM3
Curation rationale (ClinGen, verbatim)
The NM_003494.4: c.5059T>C variant in DYSF, which is also known as NM_001130987.2: c.5176T>C p.(Ser1726Pro), is a missense variant predicted to cause substitution of serine by proline at amino acid 1687, p.(Ser1687Pro). This variant has been identified in one individual with a diagnosis of LGMD, where it it was confirmed in trans with a variant classified as pathogenic by the LGMD VCEP (c.2643+1G>A, 1.0 pt, PMID: 36983702) (PM3). This patient displayed progressive limb girdle muscle weakness and significantly reduced or absent dysferlin protein expression in skeletal muscle and blood monocytes, which is highly specific for DYSF-related LGMD (PMID: 36983702; PP4_Strong). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). The computational predictor REVEL gives a score of 0.8, which exceeds the threshold of ≥0.70, evidence that correlates with impact to DYSF function (PP3). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/28/2025): PM3, PP4_Strong, PM2_Supporting, PP3.
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9219 | likely pathogenic ✓ concordant with ClinVar |
|---|---|---|
| REVEL | 0.795 | moderately pathogenic-leaning |
| SaProt | LLR -12.18 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 6.2 | GERP 2, phastCons 1 |
| Regional constraint | o/e 0.97 | unconstrained · MANE · 117 kb · p 0.28 · regional, not allelic |
| Overall | ||
| CADD | 25.2 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM S1687P vs ClinVar S1726P) — verify the residue.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- DYSF
- Protein
- p.Ser1726Pro
- Coding
- c.5176T>C
- MANE Select
- NM_001130987
- dbSNP
- rs1573060017
- Type
- single nucleotide variant
- Location
- chr2:71665163 (GRCh38)
- Gene constraint
- LOEUF 0.836 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 79.25 · 11 PDB
- Residue 1726
- a β-strand
Similar variants
- DYSF p.Ser1726= Likely benign ★ same residue
- DYSF c.1003-3C>A Pathogenic ★★★ same condition
- DYSF c.1033+1G>A Pathogenic ★★★ same condition
- DYSF c.1033+4A>T Likely pathogenic ★★★ same condition
- DYSF c.1033+5G>A Likely pathogenic ★★★ same condition
- DYSF c.1149+1G>A Pathogenic ★★★ same condition
- DYSF c.1149+1G>C Pathogenic ★★★ same condition
- DYSF c.1149+4A>G Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dysf-p-ser1726pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown